WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Lithuania elections: Incumbent president Nausėda wins first round of election
Fans flock to Paris to cheer as Lise Davidsen becomes classical music's Taylor Swift
Microsoft pledges $4.3 billion investment at Macron’s ‘Choose France’ summit
Argentina will get next installment of bailout as IMF praises Milei's austerity policies
Collapsing billboard kills 3 and hurts 59 in heavy rains in Mumbai. Scores might be trapped
Nigeria labor unions protest higher electricity prices
Supreme Court rejects an appeal from a Canadian man once held at Guantanamo
Socialists deal blow to separatists in Catalan elections but face uphill task to form government
Children are evacuated from school 'during an exam' after threat made via email
Palestinian band escapes horrors of war but members' futures remain uncertain